Literature DB >> 31594233

Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.

Brent Aulston1, Qing Liu1, Michael Mante1, Jazmin Florio1, Robert A Rissman1,2, Shauna H Yuan1.   

Abstract

Extracellular vesicles (EVs) are a heterogeneous group of secreted particles consisting of microvesicles, which are released by budding of the cellular membrane, and exosomes, which are secreted through exocytosis from multivesicular bodies. EV cargo consists of a wide range of proteins and nucleic acids that can be transferred between cells. Importantly, EVs may be pathogenically involved in neurodegenerative diseases such as Alzheimer's disease (AD). While EVs derived from AD neurons have been found to be neurotoxic in vitro, little is known about the pathological consequences of AD EVs in vivo. Furthermore, although all known familial AD (fAD) mutations involve either amyloid-β protein precursor (AβPP) or the machinery that processes AβPP, hyperphosphorylation of the microtubule associated protein tau appears to play a critical role in fAD-associated neurodegeneration, and previous reports suggest EVs may propagate tau pathology in the AD brain. Therefore, we hypothesized that fAD EVs may have a mechanistic involvement in the development of fAD-associated tau pathology. To test this, we isolated EVs from iPSC-derived neuronal cultures generated from an fAD patient harboring a A246E mutation to presenilin-1 and stereotactically injected these EVs into the hippocampi of wild-type C57BL/6 mice. Five weeks after injection, mice were euthanized and pathology evaluated. Mice injected with fAD EVs displayed increased tau phosphorylation at multiple sites relative to PBS and non-disease control EV injected groups. Moreover, fAD EV injected hippocampi contained significantly more tau inclusions in the CA1 hippocampal neuronal field than controls. In total, these findings identify EVs as a potential mediator of fAD-associated tau dysregulation and warrant future studies to investigate the therapeutic potential of EV-targeted treatments for fAD.

Entities:  

Keywords:  Alzheimer’s disease; C57BL/6; extracellular vesicles; induced pluripotent stem cells; tau; tauopathy

Year:  2019        PMID: 31594233     DOI: 10.3233/JAD-190656

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

Review 1.  Human Pluripotent Stem Cell-Derived Extracellular Vesicles: Characteristics and Applications.

Authors:  Richard Jeske; Julie Bejoy; Mark Marzano; Yan Li
Journal:  Tissue Eng Part B Rev       Date:  2020-01-16       Impact factor: 6.389

2.  Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer's Disease.

Authors:  Benjamin J Bell; Medhinee M Malvankar; Carolyn Tallon; Barbara S Slusher
Journal:  ACS Chem Neurosci       Date:  2020-10-13       Impact factor: 4.418

Review 3.  Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases.

Authors:  Margarida Beatriz; Rita Vilaça; Carla Lopes
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 4.  Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration.

Authors:  Ricardo Quiroz-Baez; Karina Hernández-Ortega; Eduardo Martínez-Martínez
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

5.  Importance of extracellular vesicle secretion at the blood-cerebrospinal fluid interface in the pathogenesis of Alzheimer's disease.

Authors:  Charysse Vandendriessche; Sriram Balusu; Caroline Van Cauwenberghe; Marjana Brkic; Marie Pauwels; Nele Plehiers; Arnout Bruggeman; Pieter Dujardin; Griet Van Imschoot; Elien Van Wonterghem; An Hendrix; Femke Baeke; Riet De Rycke; Kris Gevaert; Roosmarijn E Vandenbroucke
Journal:  Acta Neuropathol Commun       Date:  2021-08-23       Impact factor: 7.801

6.  Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons.

Authors:  Sonia Podvin; Alexander Jones; Qing Liu; Brent Aulston; Charles Mosier; Janneca Ames; Charisse Winston; Christopher B Lietz; Zhenze Jiang; Anthony J O'Donoghue; Tsuneya Ikezu; Robert A Rissman; Shauna H Yuan; Vivian Hook
Journal:  ACS Omega       Date:  2021-05-13

Review 7.  CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges.

Authors:  Simon Hornung; Suman Dutta; Gal Bitan
Journal:  Front Mol Neurosci       Date:  2020-03-19       Impact factor: 5.639

Review 8.  Extracellular Vesicles in Alzheimer's and Parkinson's Disease: Small Entities with Large Consequences.

Authors:  Charysse Vandendriessche; Arnout Bruggeman; Caroline Van Cauwenberghe; Roosmarijn E Vandenbroucke
Journal:  Cells       Date:  2020-11-15       Impact factor: 6.600

Review 9.  MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease?

Authors:  Gurjit Singh; Kenneth B Storey
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

Review 10.  In sickness and in health: The functional role of extracellular vesicles in physiology and pathology in vivo: Part II: Pathology: Part II: Pathology.

Authors:  Abi G Yates; Ryan C Pink; Uta Erdbrügger; Pia R-M Siljander; Elizabeth R Dellar; Paschalia Pantazi; Naveed Akbar; William R Cooke; Manu Vatish; Emmanuel Dias-Neto; Daniel C Anthony; Yvonne Couch
Journal:  J Extracell Vesicles       Date:  2022-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.